Hendrick Cancer Center is a clinical research site located in Abilene, Texas, United States 79601.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Hendrick Cancer Center has participated in 8 clinical trials with 1 currently active.
Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.
Sponsors: Celgene, Stemline Therapeutics, Inc., Monopar Therapeutics.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Hendrick Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hendrick Cancer Center has 8 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.
Yes — Hendrick Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.